Detalhe da pesquisa
1.
Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma-A Randomized, Placebo-Controlled Crossover Trial (MAPLE).
J Allergy Clin Immunol Pract
; 10(11): 2925-2934.e12, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863669